The role of renal function loss on circadian misalignment of cytokines EPO, IGF-1, IL-6 and TNF-alfa in chronic renal disease

Neuroendocrinology Letters

Volumn 32, Issue 2, 2011, Pages 148-153

  Van Der Putten, Karien ^a   Koch, Birgit ^b   Van Someren, Eus ^c,d,e   Wielders, Jos ^a   Ter Wee, Piet ^f   Nagtegaal, Elsbeth ^a   Gaillard, Carlo ^a,f  

^a MEANDER MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^d VU UNIVERSITY AMSTERDAM   (Netherlands)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^f VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Chronic renal disease; Erythropoietin; Glomerul filtration rate; IL 6; TNF

Indexed keywords

ERYTHROPOIETIN; HEMOGLOBIN; INTERLEUKIN 6; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; ELECTIVE SURGERY; ERYTHROPOIESIS; FEMALE; HUMAN; KIDNEY FUNCTION; MALE; OBSERVATIONAL STUDY; PROTEIN BLOOD LEVEL;

EID: 80051654897     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Brox AG, Zhang F, Guyda H, Gagnon RF (1996) Subtherapeutic erythropoietin and insulin-like growth factor-1 correct the anemia of chronic renal failure in the mouse. Kidney Int. 50: 937-943. (Pubitemid 26302683)
2. Buemi M, Allegra A, Laganà A, Aloisi C, Privitera M, Morabito N, Frisina N (1993) Effects of the evening i.v. administration of erythropoietin in haemodialyzed patients. Riv Eur Sci Med Farmacol. 15: 195-197.
3. Cahan C, Decker MJ, Arnold JL, Washington LH, Veldhuis JD, Goldwasser E, Strohl KP (1992) Diurnal variations in serum erythropoietin levels in healthy subjects and sleep apnea patients. J Appl Physiol. 72: 2112-2117.
4. Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH, Gheeraert PJ, Missault LH, Braun JJ, Six RO, Van Der Niepen P, O'Brien E (2003) Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med. 348: 2407-2415. (Pubitemid 36682819)
5. Colao A, Di Somma C, Cascella T, Pivonello R, Vitale G, Grasso LF, Lombardi G, Savastano S (2008) Relationships between serum IGF1 levels, blood pressure, and glucose tolerance: an observational, exploratory study in 404 subjects. Eur J Endocrinol. 159: 389-397.
6. Congote LF, Sadvakassova G, Dobocan MC, Difalco MR, Li Q (2010) Erythropoietin-dependent endothelial proteins: potential use against erythropoietin resistance. Cytokine. 51: 113-118.
7. Correa PN, Axelrad AA (1991) Production of erythropoietic bursts by progenitor cells from adult human peripheral blood in an improved serum-free medium: role of insulin like growth factor 1. Blood. 78: 2823-2833.
8. Elung-Jensen T, Strandgaard S, Kamper AL (2008) Longitudinal observations on circadian blood pressure variation in chronic kidney disease stages 3-5. Nephrol Dial Transplant. 23: 2873-2878.
9. Firsov D, Bonny O (2010) Circadian regulation of renal function. Kidney Int. 78: 640-645.
10. Fisher JW (2003) Erythropoietin: physiology and pharmacology update. Exp Biol Med. (Maywood). 228: 1-14.
11. Fisher JW, Koury S, Ducey T, Mendel S (1996) Erythropoietin production by interstitial cells of hypoxic monkey kidneys. Br J Haematol. 95: 27-32. (Pubitemid 26340225)
12. Haffner D, Schaefer F, Girard J, Ritz E, Mehls O (1994) Metabolic clearance of recombinant human growth hormone in health and chronic renal failure. J Clin Invest. 93: 1163-1171. (Pubitemid 24087171)
13. Heuck C, Skjaerbaek C, Orskov H, Wolthers OD (1999) Circadian variation in serum free ultrafiltrable insulin-like growth factor I concentrations in healthy children. Pediatr Res. 45: 733-736. (Pubitemid 29203609)
14. Karasek M, Szuflet A, Chrzanowski W, Zylinska K, Swietoslawski J (2005) Decreased melatonin nocturnal concentrations in hemodialyzed patients. Neuro Endocrinol Lett. 26: 653-656.
15. Klausen T, Dela F, Hippe E, Galbo H (1993) Diurnal variations of serum erythropoietin in trained and untrained subjects. Eur J Appl Physiol Occup Physiol. 67: 545-548. (Pubitemid 24012762)
16. Koch BC, Nagtegaal JE, Hagen EC, van der Westeriaken MM, Boringa JB, Kerkhof GA, Ter Wee PM (2009) The effects of melatonin on sleep-wake rhythm of daytime haemodialysis patients: a randomized, placebo-controlled, cross-over study (EMSCAP study). Br J Clin Pharmacol. 67: 68-75.
17. Koch BC, van der Putten K, Van Someren EJ, Wielders JP, Ter Wee PM, Nagtegaal JE, Gaillard CA (2010) Impairment of endogenous melatonin rhythm is related to the degree of Chronic Kidney Disease (CREAM study). Nephrol Dial Transplant. 25: 513-519.
18. Lissoni P, Perego M, Veronese E, Fumagalli G, Brivio F, Colciago M, Messina G, Rovelli F, Brivio R, Gardani G (2004) Endocrine effects of erythropoietin in cancer patients. Hematology. 9: 363-367. (Pubitemid 40123585)
19. Lombardi G, Di Somma C, Rota F, Colao A (2005) Associated hormonal decline in aging: is there a role for GH therapy in aging men? J Endocrinol Invest. 28: 99-108.
20. Macdougall IC, Cooper AC (2005) Hyporesponsiveness to erythropoietic therapy due to chronic inflammation. Eur J Clin Invest. 35 Suppl 3: 32-35. (Pubitemid 41783602)
21. Oberg BP, McMenamin E, Lucas FL, McMonagle E, Morrow J, Ikizler TA, Himmelfarb J (2004) Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int. 65: 1009-1016. (Pubitemid 38251077)
22. Roberts D, Smith DJ (1996) Erythropoietin does not demonstrate circadian rhythm in healthy men. J Appl Physiol. 80: 847-851. (Pubitemid 26087248)
23. Schmieder RE, Langenfeld MR, Hilgers KF (1997) Endogenous erythropoietin correlates with blood pressure in essential hypertension. Am J Kidney Dis. 29: 376-382. (Pubitemid 27106559)
24. Scortegagna M, Ding K, Zhang Q, Oktay Y, Bennett MJ, Bennett M, Shelton JM, Richardson JA, Moe O, Garcia JA (2005) HIF-2alpha regulates murine hematopoietic development in an erythropoietin-dependent manner. Blood. 105: 3133-3140.
25. Sohmiya M, Kato Y (2005) Human growth hormone and insulin-like growth factor-I inhibit erythropoietin secretion from the kidneys of adult rats. J Endocrinol. 184: 199-207. (Pubitemid 40207574)
26. Stratakis CA, Mastorakos G, Magiakou MA, Papavasiliou EC, Panitsa-Faflia C, Georgiadis E, Batrinos ML (1996) 24-hour secretion of growth hormone (GH), insulin-like growth factors-I and -II (IGF-I, -II), prolactin (PRL) and thyrotropin (TSH) in young adults of normal and tall stature. Endocr Res. 22: 261-276. (Pubitemid 26299749)
27. Tönshoff B, Powell DR, Zhao D, Durham SK, Coleman ME, Domené HM, Blum WF, Baxter RC, Moore LC, Kaskel FJ (1997) Decreased hepatic insulin-like growth factor (IGF)-I and increased IGF binding protein-1 and -2 gene expression in experimental uremia. Endocrinology. 138: 938-946. (Pubitemid 27089744)
28. van der Putten K, Braam B, Jie KE, Gaillard CA (2008) Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure. Nat Clin Pract Nephrol. 4: 47-57. (Pubitemid 350308210)
29. Van Someren EJ, Nagtegaal E (2007) Improving melatonin circadian phase estimates. Sleep Med. 8: 590-601. (Pubitemid 47181212)
30. Vaziri ND, Oveisi F, Reyes GA, Zhou XJ (1996) Dysregulation of melatonin metabolism in chronic renal insufficiency: role of erythropoietin-deficiency anemia. Kidney Int. 50: 653-656. (Pubitemid 26274397)
31. Vgontzas AN, Zoumakis M, Papanicolaou DA, Bixler EO, Prolo P, Lin HM, Vela-Bueno A, Kales A, Chrousos GP (2002) Chronic insomnia is associated with a shift of interleukin-6 and tumor necrosis factor secretion from nighttime to daytime. Metabolism. 51: 887-92. (Pubitemid 34784816)